日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

One-hour postload glucose compared to prediabetes criteria as predictive markers of type 2 diabetes in Latin America

拉丁美洲2型糖尿病的预测指标:餐后1小时血糖与糖尿病前期标准的比较

Lizarzaburu-Robles, Juan Carlos; Herman, William H; Garro-Mendiola, Alonso; Mahillo-Fernandez, Ignacio; Lazo-Porras, María; Mas-Fontao, Sebastián; Paniagua, Amalia; Vázquez-Matínez, Clotilde; Vento, Flor; Valera, José; Lorenzo, Oscar

Do Immediate Perioperative Glucose Measurements Predict Outcomes in Non-Elective Pedal Amputation?

术前即刻血糖测量能否预测非择期足部截肢的预后?

Girgis, Christopher; Gaynanova, Irina; Behme, Stephanie; Herman, William H; Holmes, Crystal; Schmidt, Brian M

Hypoglycemia Beliefs, Impaired Hypoglycemia Awareness, and Severe Hypoglycemia in Insulin-Treated Type 2 Diabetes: Insights From CGM Users

胰岛素治疗的 2 型糖尿病患者的低血糖认知、低血糖感知障碍和严重低血糖:来自 CGM 用户的见解

Lin, Yu Kuei; Tang, Haoran; Ye, Wen; Ratzki-Leewing, Alexandria; Lee, Joyce; de Zoysa, Nicole; Amiel, Stephanie A; Herman, William H

Comment on Pop-Busui et al. Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure. Diabetes Care 48:2145-2153

对 Pop-Busui 等人发表于《糖尿病护理》48:2145-2153 的文章“筛查利钠肽水平可预测无已知心力衰竭的 1 型和 2 型糖尿病患者的心力衰竭和死亡”的评论

Herman, William H

Decreasing Prevalence of Chronic Kidney Disease Among U.S. Adults With Diabetes, 1999-2018

1999-2018年美国糖尿病成人慢性肾病患病率下降

Bragg-Gresham, Jennifer L; Li, Yiting; Nunes, Julie Wright; Herman, William H; Powe, Neil R; Banerjee, Tanushree; Morgenstern, Hal; Stack, Austin G; Veinot, Tiffany C; Saran, Rajiv

C-951-06. Metabolomic Profiling of Lipid and Metabolic Alterations in Burn Injury: Identifying Biomarkers for Improved Management

C-951-06. 烧伤后脂质和代谢改变的代谢组学分析:鉴定用于改善治疗的生物标志物

Cefalu, William T; Dawes, Daniel E; Gavlak, Gina; Goldman, Dana; Herman, William H; Van Nuys, Karen; Powers, Alvin C; Taylor, Simeon I; Yatvin, Alan L; Melito, William M; Hoppe, Athena M; Smith, Alison A; Miles, M Victoria P; Schoen, Jonathan E; Carter, Jeffrey M; Vitharana, Dhanushka; Masoud, Abdul-Razak; Adamec, Jiri; Chatterjee, Sabyasachi

Estimated Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease in US Adults, 2020 to 2050

2020年至2050年美国成年人代谢功能障碍相关脂肪肝疾病的估计负担

Le, Phuc; Tatar, Moosa; Dasarathy, Srinivasan; Alkhouri, Naim; Herman, William H; Taksler, Glen B; Deshpande, Abhishek; Ye, Wen; Adekunle, Olajide A; McCullough, Arthur; Rothberg, Michael B

Value-Based Pricing of Resmetirom for Metabolic Dysfunction-Associated Steatotic Liver Disease

基于价值的瑞美替罗治疗代谢功能障碍相关脂肪肝疾病的定价

Le, Phuc; Dasarathy, Srinivasan; Herman, William H; Adekunle, Olajide A; Tran, Ha T; Criswell, Victoria; Ye, Wen; Welch, Nicole; Yue, Yihua; Rothberg, Michael B

The 2018 World Cancer Research Fund/American Institute for Cancer Research Score and Cancer Risk: results from the diabetes prevention program outcomes study

2018年世界癌症研究基金会/美国癌症研究所评分与癌症风险:糖尿病预防项目结果研究

Tjaden, Ashley H; Goldbaum, Audrey A; Edelstein, Sharon L; Heckman-Stoddard, Brandy M; Reedy, Jill; Herman, William H; Hoskin, Mary; Knowler, William C; Schlögl, Mathias; Temple, Karla A; Venditti, Elizabeth M; Watson, Karol; Temprosa, Marinella; Shams-White, Marissa M

A comment on "Metformin in the Diabetes Prevention Program 3-year trial: The cost-effectiveness that never was"

对“糖尿病预防计划3年试验中的二甲双胍:从未实现的成本效益”的评论

Herman, William H; Kuo, Shihchen; Zhang, Ping